Encapsulation of doxorubicin in chitosan-alginate nanoparticles improves its stability and cytotoxicity in resistant lymphoma L5178 MDR cells

MLA

Maria Frosini, et al. Encapsulation of Doxorubicin in Chitosan-Alginate Nanoparticles Improves Its Stability and Cytotoxicity in Resistant Lymphoma L5178 MDR Cells. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fcb0290d9b0562c86127ac917a9da792&authtype=sso&custid=ns315887.

APA

Maria Frosini, Yordan Yordanov, Ivanka Spassova, Borislav Tzankov, Daniela Kovacheva, Virginia Tzankova, Krassimira Yoncheva, & Massimo Valoti. (2020). Encapsulation of doxorubicin in chitosan-alginate nanoparticles improves its stability and cytotoxicity in resistant lymphoma L5178 MDR cells.

Chicago

Maria Frosini, Yordan Yordanov, Ivanka Spassova, Borislav Tzankov, Daniela Kovacheva, Virginia Tzankova, Krassimira Yoncheva, and Massimo Valoti. 2020. “Encapsulation of Doxorubicin in Chitosan-Alginate Nanoparticles Improves Its Stability and Cytotoxicity in Resistant Lymphoma L5178 MDR Cells,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fcb0290d9b0562c86127ac917a9da792&authtype=sso&custid=ns315887.